Jan 14, 2026
Genentech Response
3moThank you for your feedback and input. We recognize that being a large and complex company sometimes results in lengthier processes, and we continue to work on streamlining these to incorporate more agility into the way we work whenever possible. Regarding your concerns about transformation, within the context of an evolving healthcare landscape, we are evaluating our operations to ensure we remain well-positioned to deliver on our pipeline of new medicines for patients. We understand that adjustments in process can be difficult at times, and we are grateful for the contributions our teams make during these periods.